Population dynamics of mesenchymal stromal cells during culture expansion

Cytotherapy

Volumn 14, Issue 4, 2012, Pages 401-411

  Schellenberg, Anne ^a   Stiehl, Thomas ^b,c   Horn, Patrick ^b,c   Joussen, Sylvia ^a   Pallua, Norbert ^a   Ho, Anthony D ^b   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HEIDELBERG ACADEMY OF SCIENCES AND HUMANITIES   (Germany)

Author keywords

cellular aging; cellular automaton; colony forming units; computational model; limiting dilution; long term culture; mesenchymal stromal cells; senescence

Indexed keywords

ADIPOSE TISSUE; ARTICLE; CELL COMPOSITION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL HETEROGENEITY; CELL POPULATION; COLONY FORMATION; COLONY FORMING UNIT F; FIBROBLAST; MESENCHYMAL STROMA CELL; POPULATION DYNAMICS; PRIORITY JOURNAL;

EID: 84858661300     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.640669     Document Type: Article

References (57)

1. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper- Cortenbach I, Marini FC, et al. Clarifi cation of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393-5. (Pubitemid 41671625)
2. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7. (Pubitemid 44269669)
3. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fi broblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393-403.
4. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al. Precursors for fi broblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83-92.
5. Dexheimer V, Mueller S, Braatz F, Richter W. Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS ONE. 2011;6:e22980.
6. Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic effi cacy. Cell Cycle. 2007;6:2884-9.
7. DiGirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identify es samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275-81. (Pubitemid 29530211)
8. Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10:320-30. (Pubitemid 351983156)
9. Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239-48. (Pubitemid 351526200)
10. Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC. A simple modifi cation of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs. 2010;192:106-15.
11. Colter DC, Sekiya I, Prockop DJ. Identifi cation of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841-5. (Pubitemid 32642648)
12. Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, et al. Isolation of human mesenchymal stromal cells is more effi cient by red blood cell lysis. Cytotherapy. 2008;10: 676-85.
13. Buhring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann NY Acad Sci. 2009; 1176:124-34.
14. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de ZP, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009;94: 173-84.
15. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000; 113:1161-6. (Pubitemid 30229533)
16. Delorme B, Ringe J, Pontikoglou C, Gaillard J, Langonne A, Sensebe L, et al. Specifi c lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells. 2009;27:1142-51.
17. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O ' Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells. 2010;28:788-98.
18. Russell KC, Lacey MR, Gilliam JK, Tucker HA, Phinney DG, O ' Connor KC. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol Bioeng. 2011;108:2716-26.
19. Wagner W. Senescence is heterogeneous in mesenchymal stromal cells: kaleidoscopes for cellular aging. Cell Cycle. 2010;9:2923-4.
20. Hayfl ick L, Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
21. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28:707-15. (Pubitemid 30398528)
22. Noer A, Boquest AC, Collas P. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol. 2007;8:18-22.
23. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, et al. Replicative senescence of mesenchymal stem cells: a continuous and rganized process. PLoS ONE. 2008;5:e2213.
24. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C, et al. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant. 2011;20:1409-22.
25. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C, et al. Comparison of individual platelet lysates for isolation of human mesenchymal stromal cells. Cytotherapy. 2010;12:888-98.
26. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purifi cation and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615-25.
27. Staszewski R. Murphy's law of limiting dilution cloning. Stat Med 1990;9:457-61. (Pubitemid 20245416)
28. Underwood PA, Bean PA. Hazards of the limiting-dilution method of cloning hybridomas. J Immunol Methods. 1988;107:119-28. (Pubitemid 18060375)
29. Lietzke R, Unsicker K. A statistical approach to determine monoclonality after limiting cell plating of a hybridoma clone. J Immunol Methods. 1985;76:223-8. (Pubitemid 15169384)
30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-7. (Pubitemid 29282067)
31. Fraser JK, Wulur I, Alfonso Z, Zhu M, Wheeler ES. Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy. 2007;9:459-67. (Pubitemid 47386683)
32. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402-16. (Pubitemid 41541969)
33. Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J, et al. The heterogeneity of human mesenchymal stem cell preparations. Evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34:536-48.
34. Wagner W, Roderburg C, Wein F, Diehlmann A, Frankhauser M, Schubert R, et al. Molecular and secretory profi les of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells. 2007;10:2638-57.
35. Wagner W, Wein F, Roderburg C, Saffrich R, Faber A, Krause U, et al. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell - cell interaction. Exp Hematol. 2007;35:314-25. (Pubitemid 46138068)
36. Schellenberg A, Lin Q, Schueler H, Koch C, Joussen S, Denecke B, et al. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY). 2011;3:873-88.
37. Koch C, Suschek CV, Lin Q, Bork S, Goergens M, Joussen S, et al. Specifi c age-associated DNA methylation changes in human dermal fi broblasts. PLoS ONE. 2011;6:e16679.
38. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-28. (Pubitemid 32295155)
39. Noel D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, et al. Cell specifi c differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res. 2008;314:1575-84.
40. Orriss IR, Utting JC, Brandao-Burch A, Colston K, Grubb BR, Burnstock G, et al. Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate. Endocrinology. 2007;148:4208-16. (Pubitemid 47295696)
41. Fischer-Valuck BW, Barrilleaux BL, Phinney DG, Russell KC, Prockop DJ, O ' Connor KC. Migratory response of mesenchymal stem cells to acrophage migration inhibitory factor and its antagonist as a function of colony-forming effi - ciency. Biotechnol Lett. 2010;32:19-27.
42. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE. 2009; 4:e6498.
43. Peters R, Wolf MJ, Van den Broek M, Nuvolone M, Dannenmann S, Stieger B, et al. Effi cient generation of multipotent mesenchymal stem cells from umbilical cord blood in stromafree liquid culture. PLoS ONE. 2010;5:e15689.
44. Wagner W, Bork S, Lepperdinger G, Joussen S, Ma N, Strunk D, et al. How to track cellular aging of mesenchymal stromal cells. Aging (Albany NY). 2010;2:224-30.
45. Smith JR, Braunschweiger KI. Growth of human embryonic fi broblasts at clonal density: concordance with results from mass cultures. J Cell Physiol. 1979;98:597-601. (Pubitemid 9127637)
46. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Age-related intrinsic changes in human bonemarrow- derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335-43. (Pubitemid 351663902)
47. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14.
48. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919-26. (Pubitemid 37543568)
49. Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol. 2005;40:926-30. (Pubitemid 41682392)
50. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675-82. (Pubitemid 39172200)
51. Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW, et al. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif. 2009;42:711-20.
52. Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007;6:745-57. (Pubitemid 350131043)
53. Holzwarth C, Vaegler M, Gieseke F, Pfi ster SM, Handgretinger R, Kerst G, et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 2010;11:11.
54. Lindner U, Kramer J, Behrends J, Driller B, Wendler NO, Boehrnsen F, et al. Improved proliferation and differentiation capacity of human mesenchymal stromal cells cultured with basement-membrane extracellular matrix proteins. Cytotherapy. 2010;12:992-1005.
55. Bork S, Pfi ster S, Witt H, Horn P, Korn B, Ho AD, et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell. 2010;9:54-63.
56. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol. 2002;20:682-8. (Pubitemid 34734134)
57. Blackburn EH. Telomere states and cell fates. Nature. 2000;408:53-6.